The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

Completed · Phase 4

Conditions studied: GERD Gastroesophageal Reflux Disease

In brief

This study compares mechanical sphincter augmentation (LINX Reflux Management System) to double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to gastroesophageal reflux disease (GERD).

Key facts

Study ID
NCT02505945
Run by
Torax Medical Incorporated
People needed
152
Starts
2015-06-01
Expected to finish
2018-08-01
Last updated by the study team
2019-01-07

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.